Skip to main content

Epoch Wins SBIR Grant to Develop MGB High-Throughput Technology

NEW YORK, Dec. 11 - Epoch Biosciences has been awarded an $872,000 Small Business Innovation Research grant from the National Institutes of Health research grant, the company said on Tuesday.

 

The Phase II grant, entitled "Rapid Genotyping with Minor-Groove-Binder-Containing Probes," will span two years and will help Epoch develop a prototype kit for high-throughput DNA fingerprinting that uses probes containing Epoch's Minor Groove Binder technology.

 

According to the Bothell, Wash.-based molecular tools manufacturer, the MGB technology can enhance the ability of oligonucleotide probes to discriminate SNPs.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.